Bay­er AG taps Pep­tiDream in bil­lion-dol­lar deal

Con­tin­u­ing to beef up its pipeline in the wake of this year’s string of R&D deals, Bay­er AG has be­come the lat­est Big Phar­ma part­ner …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.